Notes: February 4, 2014 -- CEL-SCI Corporation (NYSE MKT: CVM) announced today that the warrants issued in connection with the public offerings in October and December 2013 are approved for trading on the NYSE MKT and will begin trading on February 7, 2014 under the ticker symbol CVM WS. CEL-SCI issued 25,713,095 warrants to over 250 investors who participated in the public offerings. The warrants are exercisable at $1.25 and expire on October 11, 2018. These warrants were previously approved for trading on the OTC Bulletin Board under the ticker symbol CSCIW. CEL-SCI also received approval for electronic delivery of the warrants from the Depository Trust Company. Investors who participated in the public offering were sent information by mail from Computershare Trust Company (the Warrant Agent) with instructions on how to trade in the old warrants for new warrants certificates that can be deposited with a broker electronically._______________September 20, 2013 -- CEL-SCI Corporation (NYSE MKT: CVM) , a late-stage oncology company, announced that it is effecting a 1-for-10 reverse stock split of its common stock which will be effective for trading purposes as of the commencement of trading on September 25, 2013. As of that date, each 10 shares of issued and outstanding common stock and equivalents will be converted into 1 share of common stock. The number of outstanding common shares will be reduced from 310,005,272 to approximately 31 million.